Biogen has announced that the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have started ...

Novo Nordisk’s Ozempic (semaglutide) has been approved by the US Food and Drug Administration (FDA) to reduce the risk of ...

Bayer Consumer Health has launched a digital educational resource to support perimenopausal or menopausal patients in the UK.

AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved by the US Food and Drug ...

Roche and Sarepta Therapeutics have shared positive top-line results from a late-stage study of Elevidys (delandistrogene ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

Bristol Myers Squibb (BMS) has shared promising results from a late-stage study of its dual immunotherapy combination in ...

We are delighted to announce that market access and HEOR experts from Mtech Access - Powered by Petauri will be attending ...

Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab-irmb) has been approved by the US Food and Drug ...

Pfizer has shared positive results from a late-stage study of its Braftovi (encorafenib) combination in BRAF V600E-mutant ...

Havas Health Network has launched Havas Life London, an evolution of Havas Life Medicom that is “deeply rooted” in the agency ...